SKU(재고 관리 코드):SEB430Mu
ELISA Kit for Semaphorin 4D (SEMA4D)
ELISA Kit for Semaphorin 4D (SEMA4D)
Enzyme-linked immunosorbent assay for Antigen Detection.
Product No.
SEB430Mu
Organism Species
Mus musculus (Mouse).
Sample Type
serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
Test Method
Double-antibody Sandwich
Assay Length
3h
Detection Range
0.78-50ng/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 0.30ng/mL.
UOM
48T 96T 96T*5 96T*10 96T*100
Specificity
This assay has high sensitivity and excellent specificity for detection of Semaphorin 4D (SEMA4D).
No significant cross-reactivity or interference between Semaphorin 4D (SEMA4D) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Semaphorin 4D (SEMA4D) and the recovery rates were calculated by comparing the measured value to the expected amount of Semaphorin 4D (SEMA4D) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 80-98 | 88 |
EDTA plasma(n=5) | 98-105 | 102 |
heparin plasma(n=5) | 88-102 | 91 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Semaphorin 4D (SEMA4D) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Semaphorin 4D (SEMA4D) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Semaphorin 4D (SEMA4D) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 99-105% | 78-90% | 87-94% | 99-105% |
EDTA plasma(n=5) | 94-105% | 83-98% | 92-101% | 88-96% |
heparin plasma(n=5) | 80-91% | 94-103% | 82-90% | 89-102% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.
Magazine | Citations |
Expert Opin Ther Targets. | Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment Pubmed:25395071 |
Obesity (Silver Spring). | Genome-wide analysis identifies an african-specific variant in SEMA4D associated with body mass index. pubmed:28296344 |
Clinical Lymphoma, Myeloma & Leukemia | A Revised Staging System for Waldenström's Macroglobulinemia 10.1016/j.clml.2017.07.146 |
Clinical Lymphoma, Myeloma & Leukemia | Extramedullary Multiple Myeloma: Clinical Features and Prognosis in Argentina 10.1016/j.clml.2017.07.144 |
Blood Cancer Journal | Semaphorin 4D correlates with increased bone resorption, hypercalcemia, and disease stage in newly diagnosed patients with multiple myeloma Pubmed:29748532 |
Analytical Biochemistry | A high-sensitivity enzyme immunoassay for the quantification of soluble human semaphorin 4D in plasma Pubmed: 30879960 |
Journal of Allergy and Clinical Immunology-In Practice | Pathological and therapeutic implications of eosinophil-derived semaphorin 4D in eosinophilic chronic rhinosinusitis Pubmed: 32035658 |
Catalog No. | Related products for research use of Mus musculus (Mouse) Organism species | Applications (RESEARCH USE ONLY!) |
RPB430Mu01 | Recombinant Semaphorin 4D (SEMA4D) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB430Mu02 | Recombinant Semaphorin 4D (SEMA4D) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB430Mu02 | Polyclonal Antibody to Semaphorin 4D (SEMA4D) | WB; IHC; ICC; IP. |
PAB430Mu01 | Polyclonal Antibody to Semaphorin 4D (SEMA4D) | WB; IHC; ICC; IP. |
SEB430Mu | ELISA Kit for Semaphorin 4D (SEMA4D) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB430Mu | Magnetic Luminex Assay Kit for Semaphorin 4D (SEMA4D) ,etc. | Magnetic Luminex Assay for Antigen Detection. |